Detail page

Knowledge Web

Person

Tanja Schimek-Jasch

Ärztin

Name	Tanja Schimek-Jasch
Place	Friedrichshafen (Geburtsort) Deutschland
Profession	Ärztin (characteristic profession)
Variant	Tanja Schimek- Jasch Tanja Schimek (früherer Name)
Further information	Diss. 2017, Albert-Ludwigs-Universität freiburg i. Br., Medizinische Fakultät
Record type	Person
GND-Identifier	1131079191
Record ID	1131079191
Involved in show all Cardiac function modifies the impact of heart base dose on survival: a voxel-wise analysis of lung cancer patients from the PET-Plan trial FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation? Changes in blood biomarkers of angiogenesis and immune modulation after radiation therapy and their association with outcomes in thoracic malignancies FDG-PET radiomics for response monitoring in non-small-cell lung cancer treated with radiation therapy FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation? Efficacy and toxicity of different chemotherapy protocols for concurrent chemoradiation in non-small cell lung cancer - a secondary analysis of the PET plan trial Immunohistochemistry and radiomic features for survival prediction in small cell lung cancer Klinisch-retrospektive Evaluation der konsolidierenden thorakalen Strahlentherapie bei Patienten mit kleinzelligem Lungenkarzinom im Stadium „extensive disease“ Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? Radiochemotherapie des Analkarzinoms und anschließende Erhaltungschemotherapie : monozentrische Freiburger Ergebnisse Using a contextualized sensemaking model for interaction design : : a case study of tumor contouring Visualization of 4D multimodal imaging data and its applications in radiotherapy planning Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1)

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Tanja Schimek-Jasch

Cardiac function modifies the impact of heart base dose on survival: a voxel-wise analysis of lung cancer patients from the PET-Plan trial

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?

Changes in blood biomarkers of angiogenesis and immune modulation after radiation therapy and their association with outcomes in thoracic malignancies

FDG-PET radiomics for response monitoring in non-small-cell lung cancer treated with radiation therapy

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?

Efficacy and toxicity of different chemotherapy protocols for concurrent chemoradiation in non-small cell lung cancer - a secondary analysis of the PET plan trial

Immunohistochemistry and radiomic features for survival prediction in small cell lung cancer

Klinisch-retrospektive Evaluation der konsolidierenden thorakalen Strahlentherapie bei Patienten mit kleinzelligem Lungenkarzinom im Stadium „extensive disease“

Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Radiochemotherapie des Analkarzinoms und anschließende Erhaltungschemotherapie : monozentrische Freiburger Ergebnisse

Using a contextualized sensemaking model for interaction design : : a case study of tumor contouring

Visualization of 4D multimodal imaging data and its applications in radiotherapy planning

Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1)